Experts and Doctors on treatment outcome in San Giovanni Rotondo, Apulia, Italy

Summary

Locale: San Giovanni Rotondo, Apulia, Italy
Topic: treatment outcome

Top Publications

  1. Mangia A, Mottola L, Santoro R. Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients. World J Gastroenterol. 2013;19:8924-8 pubmed publisher
    ..Simple size of the studies and GT-2 and GT-3 proportion were discussed. An algorithm for the practical use of IL28B in these patients was suggested at the aim of optimizing treatment. ..
  2. Andriulli A, Annese V, Caruso N, Pilotto A, Accadia L, Niro A, et al. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. Am J Gastroenterol. 2005;100:207-19 pubmed
    ..To perform meta-analyses of studies on outcome of bleeding ulcers of different proton-pump inhibitors (PPIs) regimens, after stratification of patients by endoscopic stigmata, and analysis of studies with and without endotherapy...
  3. Corsa P, Parisi S, Raguso A, Troiano M, Perrone A, Cossa S, et al. Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. Tumori. 2006;92:299-305 pubmed
    ..Temozolomide, a novel alkylating agent, has shown promising results in the treatment of patients with high-grade gliomas, when used as single agent as well as in combination with radiation therapy...
  4. Iacobellis A, Perri F, Valvano M, Caruso N, Niro G, Andriulli A. Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis. Clin Gastroenterol Hepatol. 2011;9:249-53 pubmed publisher
    ..Among patients with cirrhosis that is a result of HCV infection and who have progressed to a stage of liver decompensation, an SVR after antiviral therapy is a positive prognostic factor. ..
  5. Muscarella L, Barbano R, D Angelo V, Copetti M, Coco M, Balsamo T, et al. Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. Epigenetics. 2011;6:317-25 pubmed
    ..54, 95% CI 1.35-22.74). Our results further suggest that KEAP1 expression is epigenetically regulated. In addition we demonstrated that KEAP1 is frequently methylated in malignant gliomas and a predictor of patient's outcome. ..
  6. Mangia A, Mottola L. What's new in HCV genotype 2 treatment. Liver Int. 2012;32 Suppl 1:135-40 pubmed publisher
    ..Existing results suggest that the genetic evaluation of IL28B may be useful in patients with HCV-2 for predicting response in patients without RVR. ..